Prognostic factors in post-prostatectomy salvage radiotherapy setting with and without hormonotherapy: An individual patient data analysis of randomized trials from ICECaP database
By using a composite score of pathology grading (Gleason Score), PSA at start of salvage radiation and margin status data, physicians can provide patients with more refined information on the risk of a second relapse after receiving radiation to the prostate bed after a prostatectomy for a rising or persistent PSA, both with and without hormonal therapy.
Authors
- Silke Gillessen (ORCID: https://orcid.org/0000-0001-5746-6555)
- Felix Yi-Chung Feng (ORCID: https://orcid.org/0000-0002-0963-7687)
- C. Carrié (ORCID: https://orcid.org/0000-0002-0766-2547)
- Bertrand F. TOMBAL (ORCID: https://orcid.org/0000-0002-0093-8408)
- Paul Sargos (ORCID: https://orcid.org/0000-0002-7301-0870)
- Praful Ravi (ORCID: https://orcid.org/0000-0002-7466-4702)
- Hendrik Van Poppel (ORCID: https://orcid.org/0000-0002-7458-8578)
- Wanling Xie (ORCID: https://orcid.org/0000-0001-5995-8000)
- Daniel Eidelberg Spratt (ORCID: https://orcid.org/0000-0002-5973-4741)
- P. Pommier (ORCID: https://orcid.org/0000-0001-9903-2747)
- Christopher Sweeney
- James J. Dignam
Institutions
- Cliniques Universitaires Saint-Luc (BE)
- University of California, San Francisco (US)
- University of Chicago (US)
- Institute of Oncology Research (CH)
- Centre Léon Bérard (FR)
- Dana-Farber Cancer Institute (US)
- University Hospitals Seidman Cancer Center (US)
- Institut Bergonié (FR)
- Centre for Cancer Biology (AU)
- Physique des Cellules et Cancers (FR)
- UCSF Helen Diller Family Comprehensive Cancer Center (US)
- The University of Adelaide (AU)
- Case Western Reserve University (US)
- Institut Curie (FR)
- KU Leuven (BE)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1016/j.radonc.2024.110532
- Citations
- 3
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- Prostate Cancer Foundation